57 related articles for article (PubMed ID: 22547152)
1. The preoperative predictive factors for pathological T3a upstaging and positive surgical margin of clinical T1 renal cell carcinoma.
Çil G; Yilmaz M; Sahin Y; Ulus I; Canıtez IO; Kandıralı IE
Actas Urol Esp (Engl Ed); 2024 May; 48(4):311-318. PubMed ID: 38369290
[TBL] [Abstract][Full Text] [Related]
2. ctDNA predicts clinical T1a to pathological T3a upstaging after partial nephrectomy.
Park JS; Kim H; Jang WS; Kim J; Ham WS; Lee ST
Cancer Sci; 2024 May; 115(5):1680-1687. PubMed ID: 38475661
[TBL] [Abstract][Full Text] [Related]
3. Computer tomography-based shape of tumor contour and texture of tumor heterogeneity are independent prognostic indicators for clinical T1b-T2 renal cell carcinoma.
Song B; Hwang SI; Lee HJ; Lee H; Oh JJ; Lee S; Hong SK; Byun SS; Kim JK
World J Urol; 2023 Oct; 41(10):2723-2734. PubMed ID: 37530807
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis is a strong predictor for recurrence in patients with pathological T1a renal cell carcinoma.
Ito K; Seguchi K; Shimazaki H; Takahashi E; Tasaki S; Kuroda K; Sato A; Asakuma J; Horiguchi A; Asano T
Oncol Lett; 2015 Jan; 9(1):125-130. PubMed ID: 25435945
[TBL] [Abstract][Full Text] [Related]
5. Impact of Time-To-Surgery on the Prognosis of Patients with T1 Renal Cell Carcinoma: Implications for the COVID-19 Pandemic.
Ou W; Wang C; Un H; Guo S; Xiao H; Huang B; Li B; Lei J; Wei J; Peng S; Luo J; Wang Z; Chen L
J Clin Med; 2022 Dec; 11(24):. PubMed ID: 36556133
[TBL] [Abstract][Full Text] [Related]
6. The Evolving Clinical Management of Genitourinary Cancers Amid the COVID-19 Pandemic.
Izadmehr S; Lundon DJ; Mohamed N; Katims A; Patel V; Eilender B; Mehrazin R; Badani KK; Sfakianos JP; Tsao CK; Wiklund P; Oh WK; Cordon-Cardo C; Tewari AK; Galsky MD; Kyprianou N
Front Oncol; 2021; 11():734963. PubMed ID: 34646777
[TBL] [Abstract][Full Text] [Related]
7. Nephrectomy Delay of More than 10 Weeks from Diagnosis Is Associated with Decreased Overall Survival in pT3 RCC.
Zeng J; Batai K; Lee BR
J Kidney Cancer VHL; 2021; 8(2):27-33. PubMed ID: 34178583
[TBL] [Abstract][Full Text] [Related]
8. What is Elective Oncologic Surgery in the Time of COVID-19? A Literature Review of the Impact of Surgical Delays on Outcomes in Patients with Cancer.
Garcia D; Siegel JB; Mahvi DA; Zhang B; Mahvi DM; Camp ER; Graybill W; Savage SJ; Giordano A; Giordano S; Carneiro-Pla D; Javid M; Lesher AP; Abbott A; DeMore NK
Clin Oncol Res; 2020 Jun; 3(6):1-11. PubMed ID: 34142081
[TBL] [Abstract][Full Text] [Related]
9. Delayed surgery for localised and metastatic renal cell carcinoma: a systematic review and meta-analysis for the COVID-19 pandemic.
Chan VW; Tan WS; Leow JJ; Tan WP; Ong WLK; Chiu PK; Gurung P; Pirola GM; Orecchia L; Liew MPC; Lee HY; Wang Y; Chen IA; Castellani D; Wroclawski ML; Mayor N; Sathianathen NJ; Braga I; Liu Z; Moon D; Tikkinen K; Kamat A; Meng M; Ficarra V; Giannarini G; Teoh JY
World J Urol; 2021 Dec; 39(12):4295-4303. PubMed ID: 34031748
[TBL] [Abstract][Full Text] [Related]
10. Delaying surgery for clinical T1b-T2bN0M0 renal cell carcinoma: Oncologic implications in the COVID-19 era and beyond.
Srivastava A; Patel HV; Kim S; Shinder B; Sterling J; Tabakin AL; Polotti CF; Saraiya B; Mayer T; Kim IY; Ghodoussipour S; Patel HD; Jang TL; Singer EA
Urol Oncol; 2021 May; 39(5):247-257. PubMed ID: 33223368
[TBL] [Abstract][Full Text] [Related]
11. Association of Surgical Delay and Overall Survival in Patients With T2 Renal Masses: Implications for Critical Clinical Decision-making During the COVID-19 Pandemic.
Ginsburg KB; Curtis GL; Patel DN; Chen WM; Strother MC; Kutikov A; Derweesh IH; Cher ML
Urology; 2021 Jan; 147():50-56. PubMed ID: 32966822
[TBL] [Abstract][Full Text] [Related]
12. Urologic oncology practice during COVID-19 pandemic: A systematic review on what can be deferrable vs. nondeferrable.
Katims AB; Razdan S; Eilender BM; Wiklund P; Tewari AK; Kyprianou N; Badani KK; Mehrazin R
Urol Oncol; 2020 Oct; 38(10):783-792. PubMed ID: 32703636
[TBL] [Abstract][Full Text] [Related]
13. The impact of delaying radical nephrectomy for stage II or higher renal cell carcinoma.
Kim KH; You D; Jeong IG; Song C; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2012 Sep; 138(9):1561-7. PubMed ID: 22547152
[TBL] [Abstract][Full Text] [Related]
14. The effect of delaying nephrectomy on oncologic outcomes in patients with renal tumors greater than 4cm.
Mano R; Vertosick EA; Hakimi AA; Sternberg IA; Sjoberg DD; Bernstein M; Dalbagni G; Coleman JA; Russo P
Urol Oncol; 2016 May; 34(5):239.e1-8. PubMed ID: 26795607
[TBL] [Abstract][Full Text] [Related]
15. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
16. Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging.
Jeong SH; Kim JK; Park J; Jeon HJ; Yoon MY; Jeong CW; Ku JH; Kim HH; Kwak C
PLoS One; 2016; 11(11):e0166183. PubMed ID: 27861519
[TBL] [Abstract][Full Text] [Related]
17. Analysis of long-term survival in patients with localized renal cell carcinoma: laparoscopic versus open radical nephrectomy.
Luo JH; Zhou FJ; Xie D; Zhang ZL; Liao B; Zhao HW; Dai YP; Chen LW; Chen W
World J Urol; 2010 Jun; 28(3):289-93. PubMed ID: 19916010
[TBL] [Abstract][Full Text] [Related]
18. Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.
Krejci KG; Blute ML; Cheville JC; Sebo TJ; Lohse CM; Zincke H
Urology; 2003 Oct; 62(4):641-6. PubMed ID: 14550434
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
